Quote:

---

The company is built around its well known drug Leronlimab (PRO 140), an initial several million dollar investment that has since ballooned to 32 investments. However, confusing messaging and an attempt to be a "jack of all trades" means the company's future shareholder return potential is limited.

---

That quote just goes to show the inanity of the writing. Having a drug that is a jack of all trades with 32 indications would hardly limit the potential return.